Standard Biotools (LAB) Cash from Investing Activities Growth (5y) (2015 - 2026)
Powered by 
Analysis
Standard Biotools (LAB) Cash from Investing Activities Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.48 Bn | 221.41 Bn | 8.34 Bn |
| 2 | Danaher | 144.42 Bn | 140.08 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn |
| 4 | Illumina | 30.97 Bn | 29.80 Bn | 770.00 Mn |
| 5 | Revvity | 13.85 Bn | 12.83 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn |
| 8 | Repligen | 9.33 Bn | 8.31 Bn | 110.04 Mn |
| 9 | 10x Genomics | 8.77 Bn | 8.21 Bn | 112.50 Mn |
| 10 | Standard Biotools | 285.26 Mn | -191.45 Mn | 10.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29.09% |
| Mar 31, 2026 | 109.97% |
| Dec 31, 2025 | -57.79% |
| Sep 30, 2025 | -20.17% |
| Jun 30, 2025 | 22.12% |
| Mar 31, 2025 | -3.48% |
| Dec 31, 2024 | 117.51% |
| Sep 30, 2024 | -46.36% |
| Jun 30, 2024 | 27.84% |
| Mar 31, 2024 | 103.15% |
| Dec 31, 2023 | -269.67% |
| Sep 30, 2023 | -129.92% |
| Jun 30, 2023 | 57.06% |
| Mar 31, 2023 | 178.01% |
| Dec 31, 2022 | 65.39% |
| Sep 30, 2022 | 88.76% |
| Jun 30, 2022 | -109.67% |
| Mar 31, 2022 | -15.43% |
| Sep 30, 2021 | -25.39% |
| Jun 30, 2021 | -101.41% |